Cargando…

Assessment of serological assays for identifying high titer convalescent plasma

Mostrar otras versiones (1)

The COVID-19 pandemic has been accompanied by the largest mobilization of therapeutic convalescent plasma (CCP) in over a century. Initial identification of high titer units was based on dose-response data using the Ortho VITROS IgG assay. The proliferation of SARS-CoV-2 serological assays and non-u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farnsworth, Christopher W., Case, James Brett, Hock, Karl, Chen, Rita E., O’Halloran, Jane A., Presti, Rachel, Goss, Charles W., Rauseo, Adriana M., Ellebedy, Ali, Theel, Elitza S., Diamond, Michael S., Henderson, Jeffrey P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010743/ https://www.ncbi.nlm.nih.gov/pubmed/33791711 http://dx.doi.org/10.1101/2021.03.26.21254427

Ejemplares similares

Assessment of serological assays for identifying high titer convalescent plasma
por: Farnsworth, Christopher W., et al.
Publicado: (2021)

Limited Correlation between SARS-CoV-2 Serologic Assays for Identification of High-Titer COVID-19 Convalescent Plasma Using FDA Thresholds
por: Larkey, Nicholas E., et al.
Publicado: (2022)

Performance Characteristics of High-Throughput Serologic Assays for Severe Acute Respiratory Syndrome Coronavirus 2 with Food and Drug Administration Emergency Use Authorization: A Review
por: Theel, Elitza S.
Publicado: (2022)

SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans
por: Turner, Jackson S., et al.
Publicado: (2020)

What Are the Clinical Implications of the SARS-CoV-2 Variants: 5 Things Every Cardiologist Should Know
por: Rauseo, Adriana M., et al.
Publicado: (2021)

Asthma in patients with suspected and diagnosed coronavirus disease 2019
por: Cao, Lijuan, et al.
Publicado: (2021)

Non-neutralizing antibodies and limitations of serologic testing for severe acute respiratory syndrome coronavirus 2 in patients receiving immunoglobulin replacement products
por: Manian, Deepti Vellaichamy, et al.
Publicado: (2021)

753. Performance Characteristics of Diagnostic Assays in Blastomycosis
por: O’Dowd, Timothy, et al.
Publicado: (2020)

Effect of time and titer in convalescent plasma therapy for COVID-19
por: de Candia, Paola, et al.
Publicado: (2021)

Long-Term Mortality after Histoplasma Infection in People with HIV
por: Cherabie, Joseph, et al.
Publicado: (2021)

Evaluation of the genalyte maverick SARS-CoV-2 multi-antigen serology panel
por: Donato, Leslie J., et al.
Publicado: (2021)

Influence of sample collection tube method, anticoagulant-containing plasma versus serum, on influenza virus hemagglutination inhibition titer and microneutralization titer serological assays
por: Morrison, Brian J., et al.
Publicado: (2018)

The Evidence for High-Titer Convalescent Plasma in SARS-CoV-2
por: Fisher, David L., et al.
Publicado: (2021)

Vaccine-boosted convalescent plasma therapy for patients with immunosuppression and COVID-19
por: Ripoll, Juan G., et al.
Publicado: (2022)

Longitudinal analysis of clinical serology assay performance and neutralising antibody levels in COVID19 convalescents
por: Muecksch, Frauke, et al.
Publicado: (2020)

Serologic titers to Leptospira in vaccinated pigs and interpretation for surveillance
por: Schommer, Susan K., et al.
Publicado: (2021)

Immunity to SARS-CoV-2: What Do We Know and Should We Be Testing for It?
por: Misra, Anisha, et al.
Publicado: (2022)

Assessment of automated high-throughput serological assays for prediction of high-titer SARS-CoV-2 neutralizing antibody
por: Moscato, Giovanna, et al.
Publicado: (2021)

Strangles, convalescent Streptococcus equi subspecies equi M antibody titers, and presence of complications
por: Delph, Katherine M., et al.
Publicado: (2018)

Early high-titer convalescent plasma therapy in patients with moderate and severe COVID-19
por: Fazeli, Alieh, et al.
Publicado: (2022)

Impact of pathogen reduction technology on neutralizing antibody titer in COVID-19 convalescent plasma
por: Franchini, Massimo, et al.
Publicado: (2022)

Early administration of COVID‐19 convalescent plasma with high titer antibody content by live viral neutralization assay is associated with modest clinical efficacy
por: Belov, Artur, et al.
Publicado: (2022)

Molecular and Direct Detection Tests for Treponema pallidum Subspecies pallidum: A Review of the Literature, 1964–2017
por: Theel, Elitza S, et al.
Publicado: (2020)

Trends in Q fever serologic testing by immunofluorescence from four large reference laboratories in the United States, 2012–2016
por: Miller, Halie K., et al.
Publicado: (2018)

COVID-19 convalescent plasma boosts early antibody titer and does not influence the adaptive immune response
por: McDyer, John F., et al.
Publicado: (2023)

The predictors of high titer of anti-SARS-CoV-2 antibody of convalescent plasma donors
por: Wardhani, Shinta Oktya, et al.
Publicado: (2021)

Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma
por: Sullivan, David J., et al.
Publicado: (2021)

Analysis of anti-Omicron neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources
por: Sullivan, David J, et al.
Publicado: (2022)

SARS-CoV-2 Serologic Assays Dependent on Dual-Antigen Binding Demonstrate Diverging Kinetics Relative to Other Antibody Detection Methods
por: Theel, Elitza S., et al.
Publicado: (2021)

1047. Weight change associated with switching to bictegravir/emtricitabine/tenofovir alafenamide in virally suppressed people with HIV
por: Vo, Daniel, et al.
Publicado: (2020)

Target specific serologic analysis of COVID-19 convalescent plasma
por: Ikegami, Sachie, et al.
Publicado: (2021)

Diagnostic Testing for Zika: Observing Rapid Translation During a Public Health Emergency
por: Kurani, Shaheen, et al.
Publicado: (2017)

Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers
por: Heaney, Christopher D., et al.
Publicado: (2021)

Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers
por: Heaney, Christopher D., et al.
Publicado: (2021)

Limited window for donation of convalescent plasma with high live-virus neutralizing antibody titers for COVID-19 immunotherapy
por: Gontu, Abhinay, et al.
Publicado: (2021)

Coronavirus Disease 2019 Convalescent Plasma and the Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Titer
por: Bloch, Evan M, et al.
Publicado: (2021)

Assessment of SARS-CoV-2 neutralizing antibody titers in breastmilk from convalescent and vaccinated mothers
por: Bäuerl, Christine, et al.
Publicado: (2023)

COVID-19 outcome is not affected by anti-CD20 or high-titer convalescent plasma in immunosuppressed patients
por: Kasten, Mary J., et al.
Publicado: (2023)

Pharmacokinetics of high-titer anti–SARS-CoV-2 human convalescent plasma in high-risk children
por: Gordon, Oren, et al.
Publicado: (2022)

Screening for SARS-CoV-2: Health Policy Implications in Low- and Middle-Income Countries
por: Hashmi, Shahrukh K., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9qtegsignc7vkbjhg2q430tm8n